ENFR
8news

Tech • IA • Crypto

TodayBriefingVideosTop 24hCryptoArchivesFavoritesTopics

AI Innovations in Health: FDA Approvals & Major Funding Highlights – June 2026

AI & HealthThursday, June 25, 2026

50 articles analyzed by AI / 146 total

Key points

Audio player
0:00 / 0:00
  • Aidoc’s AI system received FDA breakthrough device designation in 2023 for drafting radiology reports, demonstrating significant progress in automating diagnostic workflows to potentially speed and improve radiology interpretations in clinical settings.[Morningstar]
  • BrightHeart obtained CE marking in 2024 for its AI-powered prenatal ultrasound platform, facilitating enhanced prenatal diagnostics and care across Europe by enabling early and improved detection of fetal conditions with AI assistance.[Yahoo Finance]
  • UpDoc’s AI gained FDA approval in 2026 to act as a 'Concierge Doctor' between visits, allowing continuous patient health monitoring and consultation which may improve chronic disease management and patient engagement outside traditional healthcare visits.[WSJ]
  • DeepHealth expanded clinical diagnostic AI capabilities with two FDA clearances in 2026, underpinning broader AI adoption in healthcare diagnostics and potentially raising the accuracy and utility of disease detection tools used by clinicians.[GlobeNewswire]
  • UCLA Health began deploying AI technology in 2026 to enhance cancer detection accuracy and speed, particularly aiming for earlier diagnosis to improve patient outcomes and treatment effectiveness in oncology care.[FOX 11 Los Angeles]
  • New AI tools developed by 2026 predict low blood sugar in hospitalized patients, improving clinical patient management through timely early intervention, as evidenced by at least two AI innovations focused on hypoglycemia risk detection in clinical studies.[Newswise][Newswise]
  • AI-driven research identified promising new targets for CAR T cell therapy in 2026, representing a breakthrough in cancer immunotherapy that could lead to more effective treatment options for certain difficult-to-treat cancers.[News-Medical]
  • Significant funding investments are accelerating AI healthcare innovation: University College Dublin secured €9.1 million in late 2025 for AI medical applications, Dallas-Based Komen announced a $15.4 million grant to advance AI in breast cancer therapies, and Cadence raised $100 million in 2026 to scale AI in chronic care management.[University College Dublin][Dallas Innovates][HIT Consultant]

Relevant articles